Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3262341000168111 | Restylane Lyft (hyaluronic acid 20 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3262351000168113 | Restylane Lyft 20 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Restylane Lyft 20 mg/mL injection, syringe | Is a | hyaluronic acid 20 mg/mL injection, syringe | true | Inferred relationship | Some | ||
| Restylane Lyft 20 mg/mL injection, syringe | Is a | Restylane Lyft | true | Inferred relationship | Some | ||
| Restylane Lyft 20 mg/mL injection, syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Restylane Lyft 20 mg/mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Restylane Lyft 20 mg/mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 316864529 | |
| Restylane Lyft 20 mg/mL injection, syringe | has Australian BoSS | hyaluronic acid | true | Inferred relationship | Some | 316864528 | |
| Restylane Lyft 20 mg/mL injection, syringe | has intended active ingredient | hyaluronic acid | true | Inferred relationship | Some | 316864528 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Restylane Lyft 20 mg/mL injection, 1 mL syringe | has TPUU | True | Restylane Lyft 20 mg/mL injection, syringe | Inferred relationship | Some | 1 |
| Restylane Lyft 20 mg/mL injection, 1 mL syringe | has TPUU | True | Restylane Lyft 20 mg/mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR